Free Trial

MaxCyte (MXCT) 10K Form and Latest SEC Filings 2026

MaxCyte logo
$1.09 +0.07 (+6.86%)
Closing price 04:00 PM Eastern
Extended Trading
$1.08 -0.01 (-0.92%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest MaxCyte SEC Filings & Recent Activity

MaxCyte (NASDAQ:MXCT) has submitted 189+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in MaxCyte's financial statements. The most recent filing was a Form SCHEDULE 13D submitted on May 14, 2026.

Form 4
MAXCYTE, INC. Reports Ownership Change on Apr. 17, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
MaxCyte Files Current Report on Mar. 27, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
MaxCyte Files Quarterly Report on May. 13, 2026

The 10-Q contains MaxCyte's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

MaxCyte SEC Filing History

Browse MaxCyte's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/14/2026 8:44 AM
MaxCyte (1287098) Subject
RIVER GLOBAL INVESTORS LLP (1486180) Filed by
Form SCHEDULE 13D
05/13/2026 3:31 PM
MaxCyte (1287098) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2026 3:46 PM
MaxCyte (1287098) Filer
Form DEF 14A
04/29/2026 3:47 PM
MaxCyte (1287098) Filer
Form DEFA14A
04/29/2026 3:48 PM
MaxCyte (1287098) Filer
Form ARS
04/17/2026 3:14 PM
Ahuja Parmeet (2128046) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2026 3:19 PM
MaxCyte (1287098) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/10/2026 3:44 PM
Ahuja Parmeet (2128046) Reporting
MaxCyte (1287098) Issuer
Form 3
Initial statement of beneficial ownership of securities  
04/10/2026 3:45 PM
Ahuja Parmeet (2128046) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 9:16 AM
MaxCyte (1287098) Subject
MIRABELLA FINANCIAL SERVICES LLP (1538853) Filed by
Form SCHEDULE 13G/A
03/31/2026 3:12 PM
Masoud Maher (1874571) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 3:54 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2026 3:36 PM
MaxCyte (1287098) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2026 3:15 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2026 3:40 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2026 3:05 PM
MaxCyte (1287098) Issuer
Swirsky Douglas J (1375884) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 1:28 PM
CADIAN CAPITAL MANAGEMENT, LP (1423686) Filed by
MaxCyte (1287098) Subject
Form SCHEDULE 13G/A
02/05/2026 7:03 AM
Capricorn Fund Managers Ltd (1901361) Filed by
MaxCyte (1287098) Subject
Form SCHEDULE 13G
11/14/2025 12:40 PM
CADIAN CAPITAL MANAGEMENT, LP (1423686) Filed by
MaxCyte (1287098) Subject
Form SCHEDULE 13G/A
11/05/2025 4:24 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2025 8:38 AM
MaxCyte (1287098) Subject
MIRABELLA FINANCIAL SERVICES LLP (1538853) Filed by
Form SCHEDULE 13G/A
11/03/2025 10:23 AM
MaxCyte (1287098) Subject
MIRABELLA FINANCIAL SERVICES LLP (1538853) Filed by
Form SCHEDULE 13G
10/24/2025 10:50 AM
MaxCyte (1287098) Subject
RIVER GLOBAL INVESTORS LLP (1486180) Filed by
Form SCHEDULE 13D
09/22/2025 3:39 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2025 4:12 PM
Hemrajani Rekha (1771213) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2025 3:30 PM
MaxCyte (1287098) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/13/2025 6:45 PM
Brooke William W (1545337) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025 6:46 PM
DOUGLAS RICHARD (1021015) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025 6:47 PM
Erck Stanley C (1342826) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025 6:47 PM
Masoud Maher (1874571) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025 6:48 PM
MaxCyte (1287098) Issuer
Swirsky Douglas J (1375884) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 3:30 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025 3:40 PM
MaxCyte (1287098) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025 3:05 PM
Hemrajani Rekha (1771213) Reporting
MaxCyte (1287098) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/23/2025 5:48 PM
Johnston John Joseph (1874850) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 5:32 PM
Al-Wakeel Yasir B. (1650691) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 5:34 PM
BALTHROP PATRICK J (1284839) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 5:37 PM
Brooke William W (1545337) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 5:38 PM
Collins Cynthia (1405692) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 5:39 PM
DOUGLAS RICHARD (1021015) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 5:41 PM
Erck Stanley C (1342826) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
06/23/2025 5:43 PM
Hemrajani Rekha (1771213) Reporting
MaxCyte (1287098) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025 3:30 PM
MaxCyte (1287098) Filer
Form DEFA14A
(Data available from 1/1/2016 forward)

MaxCyte SEC Filings - Frequently Asked Questions

MaxCyte (MXCT) has submitted 189+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

MaxCyte's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on MaxCyte's financial statements page.

The most recent filing was a Form SCHEDULE 13D submitted on May 14, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:MXCT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners